Welcia Holdings Co., Ltd. (3141.T)
- Previous Close
2,310.00 - Open
2,295.50 - Bid --
- Ask --
- Day's Range
2,268.50 - 2,299.50 - 52 Week Range
2,239.00 - 3,200.00 - Volume
771,600 - Avg. Volume
1,455,390 - Market Cap (intraday)
474.126B - Beta (5Y Monthly) -0.02
- PE Ratio (TTM)
17.92 - EPS (TTM)
128.06 - Earnings Date Jul 8, 2024 - Jul 12, 2024
- Forward Dividend & Yield 36.00 (1.57%)
- Ex-Dividend Date Aug 29, 2024
- 1y Target Est
2,842.50
Welcia Holdings Co., Ltd., together with its subsidiaries, operates a chain of drug stores with dispensing pharmacies in Japan. Its stores offer OTC products, cosmetics, household goods, food, and other products. The company also offers counseling, late-night, and long-term care services, as well as home-visit bathing and nursing care support services, as well as housing services for elderly people. It also engages in the retail of daily necessities, foods, confectionary, alcohol, etc. The company was formerly known as Growell Holdings Co., Ltd. and changed its name to Welcia Holdings Co., Ltd. in September 2012. Welcia Holdings Co., Ltd. was founded in 1935 and is headquartered in Tokyo, Japan. Welcia Holdings Co., Ltd. is a subsidiary of Aeon Co., Ltd.
www.welcia.co.jp--
Full Time Employees
February 29
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 3141.T
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3141.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3141.T
Valuation Measures
Market Cap
474.13B
Enterprise Value
526.29B
Trailing P/E
17.92
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.39
Price/Book (mrq)
1.99
Enterprise Value/Revenue
0.43
Enterprise Value/EBITDA
8.04
Financial Highlights
Profitability and Income Statement
Profit Margin
2.17%
Return on Assets (ttm)
4.92%
Return on Equity (ttm)
11.05%
Revenue (ttm)
1.22T
Net Income Avi to Common (ttm)
26.45B
Diluted EPS (ttm)
128.06
Balance Sheet and Cash Flow
Total Cash (mrq)
30.53B
Total Debt/Equity (mrq)
33.84%
Levered Free Cash Flow (ttm)
18.32B
Research Analysis: 3141.T
Company Insights: 3141.T
3141.T does not have Company Insights